معلومات عن هذه الحلقة
The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance. The top-class speakers of the series include Kay Davies (Oxford), Kevin M. Esvelt (MIT), Caroline Gutjahr (TUM), Henry T. Greely (Stanford), Dirk Inzé (Gent), Greg Newby (Broad Institute), Kai P. Purnhagen (Bayreuth), Pamela C. Ronald (UC Davis) and Jörg Vogel (HIRI/Würzburg).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
الإنجليزية
الولايات المتحدة
النص 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
البحث في الحلقات الماضية
البحث في الحلقات السابقة من Center for Advanced Studies (CAS) Research Focus CRISPR/Cas.
حلقات أخرى في هذا البودكاست
Panel discussion with Dr. Oana Dima, Prof. Dr. Caroline Gutjahr, and Prof. Dr. Kai P. Purnhagen | Moderation: Christoph von Eichhorn. The dicussion is the final event in the lecture series "Out of the Box: CRISPR/Cas".
The lecture series reflects on the consequences of the revolutionary gene editin…
The evetn is part of the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance.
Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new clas…
Sickle cell disease is one of the most prevalent diseases worldwide. Even optimal conventional care has demonstrated inferiority compared to curative options such as hematopoietic stem cell transplantation. Gene editing promises an elegant alternative cure to all patients lacking a matched donor, p…
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من Center for Advanced Studies (CAS)، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.
تعديل
شكراً على مساعدتنا في الحفاظ على قاعدة بيانات البودكاست مُحدَّثة.
